TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02568137 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01006668 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00882869 — Predictive Biomarker (PRD): XIAP mRNA
Genes: XIAP; API3; BIRC4; IAP3
Study NCT00604448 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01766427 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02479360 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02508532 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT02508532 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT04357275 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01827007 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01013831 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04845724 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT04845724 — Surrogate Endpoint (SUR): Serum phosphate
Study NCT04845724 — Surrogate Endpoint (SUR): Serum potassium
Study NCT01911975 — Predictive Biomarker (PRD): SCN9A mRNA
Genes: SCN9A; NENA
Study NCT02289755 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT01835145 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04025034 — Predictive Biomarker (PRD): TRO mRNA
Genes: TRO; KIAA1114; MAGED3
Study NCT00594633 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT00927355 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04357938 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00758303 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT01713400 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01088711 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04444700 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00524381 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02788474 — Predictive Biomarker (PRD): MMRN1 mRNA
Genes: MMRN1; ECM; EMILIN4; GPIA*; MMRN
Study NCT02788474 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02788474 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study NCT02788474 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT04428775 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04018183 — Predictive Biomarker (PRD): PTK7 mRNA
Genes: PTK7; CCK4
Study NCT04018183 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04018183 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04403165 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00537628 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT01927146 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00071838 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02122107 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05093478 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT03170245 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03170245 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01548768 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03444363 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03444363 — Surrogate Endpoint (SUR): Serum hemoglobin A1C
Study NCT00362986 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00362986 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02687178 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02687178 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00766454 — Predictive Biomarker (PRD); Safety Biomarker (SAF): GSTP1
Genes: GSTP
Study NCT02091219 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03490669 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study NCT04514367 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT00726323 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01926379 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01619358 — Predictive Biomarker (PRD): TRAF3 mRNA
Genes: TRAF3; CAP-1; CRAF1; TRAFAMN
Study NCT01619358 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT00772577 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02318927 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study NCT01581840 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02295930 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00171509 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03465410 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03465410 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT01775514 — Predictive Biomarker (PRD): CGB8 mRNA
Genes: CGB3; CGB; CGB5; CGB8
Study NCT03648996 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00093639 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00900133 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00900133 — Predictive Biomarker (PRD): Calgranulin B
Genes: S100A9; CAGB; CFAG; MRP14
Study NCT03594955 — Surrogate Endpoint (SUR): Hematologic response
Study NCT03580395 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03834272 — Predictive Biomarker (PRD): LUM mRNA
Genes: LUM; LDC; SLRR2D
Study NCT00615147 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01100736 — Predictive Biomarker (PRD): EDNRA mRNA
Genes: EDNRA; ETA; ETRA
Study NCT01100736 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT04076124 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04076124 — Safety Biomarker (SAF): BDNF
Study NCT03703596 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03703596 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03703596 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT03703596 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03125083 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT03125083 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT00300872 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00300872 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00300872 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01626430 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT00570271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04069260 — Predictive Biomarker (PRD): CTNS mRNA
Genes: CTNS
Study NCT03980379 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04546906 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03020524 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03020524 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT01081184 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT01081184 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01081184 — Safety Biomarker (SAF): BDNF
Study NCT03229252 — Predictive Biomarker (PRD): SPX mRNA
Genes: SPX; C12orf39
Study NCT04064684 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04064684 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04064684 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04064684 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT04064684 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT00845936 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03539484 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02952066 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT02278185 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04586361 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00517803 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00517803 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00517803 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00264290 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT00264290 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03115801 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03316937 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03316937 — Predictive Biomarker (PRD): IL2
Genes: IL-2; TCGF
Study NCT03316937 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT03316937 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03316937 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT03316937 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03316937 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT03316937 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03316937 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02734862 — Predictive Biomarker (PRD): CD101 mRNA
Genes: CD101; EWI101; IGSF2; V7
Study NCT00434070 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02207673 — Pharmacodynamic Biomarker (PDY): High-frequency oscillations
Study NCT01520454 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT01520454 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03093012 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00003210 — Safety Biomarker (SAF): Interleukin 12
Study NCT03508895 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03288584 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02069678 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01104987 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05297747 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02509728 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT00616447 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT01556997 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02695862 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02695862 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02097667 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT02097667 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02097667 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00923910 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT00246883 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00246883 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02832726 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06331975 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06331975 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06331975 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06331975 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02650232 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04385446 — Predictive Biomarker (PRD): MUC2 mRNA
Genes: MUC2; SMUC
Study NCT03836118 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03836118 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT00006057 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00138125 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00053820 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01968044 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04147533 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04147533 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00672542 — Predictive Biomarker (PRD): PSMB9 mRNA
Genes: PSMB9; LMP2; PSMB6i; RING12
Study NCT00672542 — Predictive Biomarker (PRD): PSMB8 mRNA
Genes: PSMB8; LMP7; PSMB5i; RING10; Y2
Study NCT00672542 — Predictive Biomarker (PRD): PSMB10 mRNA
Genes: PSMB10; LMP10; MECL1
Study NCT01201746 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02087046 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT03882827 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00577538 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04671602 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03106272 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01748500 — Predictive Biomarker (PRD): ATG5 mRNA
Genes: ATG5; APG5L; ASP
Study NCT00478660 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03241797 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT04098926 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT02549677 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02549677 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04174131 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02256644 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study NCT01433484 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03013933 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT03013933 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT03907735 — Predictive Biomarker (PRD): OXTR mRNA
Genes: OXTR
Study NCT02995902 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT04510922 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00341315 — Predictive Biomarker (PRD): DDT mRNA
Genes: DDT
Study NCT03272477 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03272477 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03808714 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT02816762 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02816762 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02816762 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01720628 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01720628 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01812083 — Safety Biomarker (SAF): Interleukin 1
Study NCT01758016 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT00464100 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01799746 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT04195750 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03911453 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00266110 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01636219 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01636219 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04000594 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02204579 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00361816 — Predictive Biomarker (PRD): NLRP5 mRNA
Genes: NLRP5; MATER; NALP5
Study NCT02793011 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02793011 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03926793 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01800695 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00290745 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00290745 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04289220 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04814355 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT01233583 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00004778 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study NCT03070730 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03183778 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00073073 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04177069 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02778776 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02778776 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00486135 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01800604 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT04467697 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04467697 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT04408092 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04364074 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00058279 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00058279 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01739283 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04324528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03393845 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03496792 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01073306 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01390701 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03837444 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03304821 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05102916 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05102916 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT04355338 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01624805 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT01624805 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03616587 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04643470 — Surrogate Endpoint (SUR): Complete renal response
Study NCT03556358 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01861171 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01904877 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04383899 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00928798 — Predictive Biomarker (PRD): FLCN mRNA
Genes: FLCN; BHD
Study NCT02147002 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04061382 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02225509 — Predictive Biomarker (PRD): FN1 mRNA
Genes: FN1; FN
Study NCT02225509 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study NCT03812263 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study NCT03812263 — Predictive Biomarker (PRD): ITGB2 mRNA
Genes: ITGB2; CD18; MFI7
Study NCT03812263 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03512990 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT00002719 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01037166 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01919879 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00121173 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00721266 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1